Literature DB >> 9808169

CD72-mediated B cell activation involves recruitment of CD19 and activation of phosphatidylinositol 3-kinase.

C Venkataraman1, P J Lu, A M Buhl, C S Chen, J C Cambier, S Bondada.   

Abstract

Occupancy of the B cell glycoprotein, CD72 results in syk-independent activation of phospholipase-C gamma and calcium mobilization. The cytoplasmic tail of CD72 does not contain an immunoreceptor tyrosine-based activation motif to directly transduce signals into the B lymphocyte. Hence, we investigated whether other coreceptors such as CD19 and its associated phosphatidylinositol 3-kinase (PI 3-K) were involved in CD72 signaling. Two specific inhibitors of PI 3-K inhibited CD72-stimulated B cell proliferation in a dose-dependent manner. Activation of B lymphocytes via CD72 resulted in recruitment and activation of PI 3-K, which was mediated by CD19. Accordingly, CD72 ligation induced CD19 tyrosine phosphorylation. Thus, lipid products generated as a result of PI 3-K activation may have an important function in CD72-mediated B lymphocyte activation. The kinetics of CD19 tyrosine phosphorylation induced by CD72 ligation were strikingly different from those seen following B cell antigen receptor (BCR) stimulation. A transient increase in the tyrosine phosphorylation of the complement receptors, CD21 and CD35 was observed in BCR- but not CD72-stimulated cells. Co-cross-linking of CD72 and CD19 failed to induce syk tyrosine phosphorylation suggesting that even under these conditions, CD72 signaling was independent of syk activation. A transient and stimulation-dependent physical association between CD19 and CD72 was observed in CD72-ligated cells. These observations suggest a mechanism by which CD72 can recruit CD19 and influence activation of CD19-associated PI 3-K, which appears to be critical for CD72-mediated B cell activation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9808169     DOI: 10.1002/(SICI)1521-4141(199810)28:10<3003::AID-IMMU3003>3.0.CO;2-W

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  5 in total

Review 1.  Positive and negative roles of CD72 in B cell function.

Authors:  Hsin-Jung Wu; Subbarao Bondada
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 2.  Molecular structure and expression of anthropic, ovine, and murine forms of complement receptor type 2.

Authors:  Dong Liu; Jian-Ying Zhu; Zhong-Xiang Niu
Journal:  Clin Vaccine Immunol       Date:  2008-04-09

Review 3.  CD19 function in central and peripheral B-cell development.

Authors:  Christopher J Del Nagro; Dennis C Otero; Amy N Anzelon; Sidne A Omori; Ravi V Kolla; Robert C Rickert
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

4.  CD72 polymorphism associated with child-onset of idiopathic thrombocytopenic purpura in Chinese patients.

Authors:  Jianhui Xu; Shihong Lu; Jie Tao; Zeping Zhou; Zhenping Chen; Ying Huang; Renchi Yang
Journal:  J Clin Immunol       Date:  2008-05       Impact factor: 8.317

5.  CD72, a coreceptor with both positive and negative effects on B lymphocyte development and function.

Authors:  Hsin-Jung Wu; Subbarao Bondada
Journal:  J Clin Immunol       Date:  2008-12-06       Impact factor: 8.542

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.